Human genetics of infectious diseases: Between proof of principle and paradigm

Journal of Clinical Investigation

Volumn 119, Issue 9, 2009, Pages 2506-2514

  Alcaïs, Alexandre ^a,b   Abel, Laurent ^a,b,c   Casanova, Jean Laurent ^a,b,c,d  

^a IMAGINE INSTITUTE   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c ROCKEFELLER UNIVERSITY   (United States)

^d HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN G;

ABSENCE OF SIDE EFFECTS; DISEASE PREDISPOSITION; GENETIC PREDISPOSITION; HERPES SIMPLEX ENCEPHALITIS; HUMAN; HUMAN GENETICS; INFECTION; INHERITANCE; MYCOBACTERIOSIS; NEUTROPENIA; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SEVERE COMBINED IMMUNODEFICIENCY; SEVERE CONGENITAL NEUTROPENIA;

COMMUNICABLE DISEASES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETICS, MEDICAL; GENOME, HUMAN; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; MALE; MODELS, GENETIC; PEDIGREE;

EID: 70349220934     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI38111     Document Type: Review

References (100)

1. Pasteur, L. 1939. Oeuvres de Pasteur, réunies et annotées par Louis Pasteur Vallery-Radot. Masson et Cie. Paris, France.
2. Nicolle, C. 1937. Destin des maladies infectieuses. Alcan. Paris, France. 301 pp.
3. Dubos, R.J. 1950. Louis Pasteur, free lance of science. Little, Brown. Boston, Massachusetts, USA. 418 pp.
4. Casanova, J.L., and Abel, L. 2007. Human genetics of infectious diseases: a unified theory. EMBO J. 26:915-922. (Pubitemid 46303582)
5. Casanova, J.L., and Abel, L. 2004. The human model: a genetic dissection of immunity to infection in natural conditions. Nat. Rev. Immunol. 4:55-66. (Pubitemid 38084132)
6. Kwiatkowski, D. 2000. Science, medicine, and the future: susceptibility to infection. BMJ. 321:1061-1065. (Pubitemid 30818781)
7. Allison, A. 2009. Observational, hypothesis-driven and genomics research strategies for analyzing inherited differences in responses to infectious diseases. Public Health Genomics. 12:41-52.
8. Alcais, A., and Abel, L. 2004. Application of genetic epidemiology to dissecting host susceptibility/ resistance to infection illustrated with the study of common mycobacterial infections. In Susceptibility to infectious diseases: the importance of host genetics. R. Bellamy, editor. Cambridge University Press. Cambridge, United Kingdom/New York, New York, USA. 7-44.
9. Sorensen, T.I., Nielsen, G.G., Andersen, P.K., and Teasdale, T.W. 1988. Genetic and environmental influences on premature death in adult adoptees. N. Engl. J. Med. 318:727-732.
10. Bruton, O.C. 1952. Agammaglobulinemia. Pediatrics. 9:722-728.
11. Allison, A.C. 1954. Protection afforded by sickle cell trait against subtertian malarian infection. Br. Med. J. 1:290-294.
12. Notarangelo, L., et al. 2006. Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee Meeting in Budapest, 2005. J. Allergy Clin. Immunol. 117:883-896.
13. Ochs, H., Smith, C.I.E., and Puck, J. 2006. Primary immunodeficiencies: a molecular and genetic approach. Oxford University Press. New York, New York, USA. 776 pp.
14. Fortin, A., Stevenson, M.M., and Gros, P. 2002. Complex genetic control of susceptibility to malaria in mice. Genes Immun. 3:177-186. (Pubitemid 38961129)
15. Casanova, J.L., et al. 2005. From idiopathic infectious diseases to novel primary immunodeficiencies. J. Allergy Clin. Immunol. 116:426-430.
16. Picard, C., Casanova, J.L., and Abel, L. 2006. Mendelian traits that confer predisposition or resistance to specific infections in humans. Curr. Opin. Immunol. 18:383-390. (Pubitemid 43965000)
17. Barnwell, J.W., Nichols, M.E., and Rubinstein, P. 1989. In vitro evaluation of the role of the Duffy blood group in erythrocyte invasion by Plasmodium vivax. J. Exp. Med. 169:1795-1802. (Pubitemid 19126834)
18. Miller, L.H., Mason, S.J., Clyde, D.F., and McGinniss, M.H. 1976. The resistance factor to Plasmodium vivax in blacks. The Duffy-blood-group genotype, FyFy. N. Engl. J. Med. 295:302-304.
19. Abel, L., and Casanova, J.L. 2000. Genetic predisposition to clinical tuberculosis: bridging the gap between simple and complex inheritance. Am. J. Hum. Genet. 67:274-277. (Pubitemid 30616732)
20. Bruton, O.C. 1962. A decade with agammaglobulinemia. J. Pediatr. 60:672-676.
21. Boztug, K., Welte, K., Zeidler, C., and Klein, C. 2008. Congenital neutropenia syndromes. Immunol. Allergy Clin. North Am. 28:259-275, vii-viii.
22. Conley, M.E., et al. 2005. Genetic analysis of patients with defects in early B-cell development. Immunol. Rev. 203:216-234. (Pubitemid 40179703)
23. Fischer, A., et al. 2005. Severe combined immunodeficiency. A model disease for molecular immunology and therapy. Immunol. Rev. 203:98-109. (Pubitemid 40179696)
24. Bonilla, M.A., et al. 1989. Effects of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with congenital agranulocytosis. N. Engl. J. Med. 320:1574-1580. (Pubitemid 19154570)
25. Gatti, R.A., Meuwissen, H.J., Allen, H.D., Hong, R., and Good, R.A. 1968. Immunological reconstitution of sex-linked lymphopenic immunological deficiency. Lancet. 2:1366-1369.
26. Good, R.A. 1987. Bone marrow transplantation for immunodeficiency diseases. Am. J. Med. Sci. 294:68-74.
27. Cavazzana-Calvo, M., et al. 2000. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science. 288:669-672. (Pubitemid 30241569)
28. Hacein-Bey-Abina, S., et al. 2003. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science. 302:415-419. (Pubitemid 37296260)
29. Hacein-Bey-Abina, S., et al. 2008. Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1. J. Clin. Invest. 118:3132-3142.
30. Gaspar, H.B., et al. 2004. Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector. Lancet. 364:2181-2187. (Pubitemid 40018447)
31. Howe, S.J., et al. 2008. Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCIDX1 patients. J. Clin. Invest. 118:3143-3150.
32. Orth, G. 2008. Host defenses against human papillomaviruses: lessons from epidermodysplasia verruciformis. Curr. Top. Microbiol. Immunol. 321:59-83.
33. Ramoz, N., et al. 2002. Mutations in two adjacent novel genes are associated with epidermodysplasia verruciformis. Nat. Genet. 32:579-581. (Pubitemid 35435168)
34. Lazarczyk, M., et al. 2008. Regulation of cellular zinc balance as a potential mechanism of EVER-mediated protection against pathogenesis by cutaneous oncogenic human papillomaviruses. J. Exp. Med. 205:35-42. (Pubitemid 351185713)
35. Purtilo, D.T., Cassel, C.K., Yang, J.P., and Harper, R. 1975. X-linked recessive progressive combined variable immunodeficiency (Duncan's disease). Lancet. 1:935-940.
36. Rigaud, S., et al. 2006. XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome. Nature. 444:110-114. (Pubitemid 44684766)
37. Picard, C., et al. 2003. Pyogenic bacterial infections in humans with IRAK-4 deficiency. Science. 299:2076-2079. (Pubitemid 36383736)
38. von Bernuth, H., et al. 2008. Pyogenic bacterial infections in humans with MyD88 deficiency. Science. 321:691-696.
39. Ku, C.L., et al. 2007. Selective predisposition to bacterial infections in IRAK-4-deficient children: IRAK- 4-dependent TLRs are otherwise redundant in protective immunity. J. Exp. Med. 204:2407-2422.
40. Jouanguy, E., et al. 1996. Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guerin infection. N. Engl. J. Med. 335:1956-1961. (Pubitemid 26428220)
41. Newport, M.J., et al. 1996. A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection. N. Engl. J. Med. 335:1941-1949. (Pubitemid 26428218)
42. Casanova, J.L., and Abel, L. 2002. Genetic dissection of immunity to mycobacteria: the human model. Annu. Rev. Immunol. 20:581-620. (Pubitemid 34293435)
43. Filipe-Santos, O., et al. 2006. Inborn errors of IL-12/23- and IFN-gamma-mediated immunity: molecular, cellular, and clinical features. Semin. Immunol. 18:347-361. (Pubitemid 44540199)
44. Fieschi, C., et al. 2003. Low penetrance, broad resistance, and favorable outcome of interleukin 12 receptor beta1 deficiency: medical and immunological implications. J. Exp. Med. 197:527-535. (Pubitemid 36278607)
45. Vanhollebeke, B., et al. 2006. Human Trypanosoma evansi infection linked to a lack of apolipoprotein L-I. N. Engl. J. Med. 355:2752-2756. (Pubitemid 46021512)
46. Casrouge, A., et al. 2006. Herpes simplex virus encephalitis in human UNC-93B deficiency. Science. 314:308-312. (Pubitemid 44571977)
47. Zhang, S.-Y., et al. 2007. TLR3 deficiency in otherwise healthy patients with herpes simplex encephalitis. Science. 317:1522-1527.
48. Sancho-Shimizu, V., et al. 2007. Genetic susceptibility to herpes simplex virus 1 encephalitis in mice and humans. Curr. Opin. Allergy Clin. Immunol. 7:495-505. (Pubitemid 350076444)
49. Zhang, S.Y., et al. 2007. Human Toll-like receptordependent induction of interferons in protective immunity to viruses. Immunol. Rev. 220:225-236.
50. Tournamille, C., Colin, Y., Cartron, J.P., and Le Van Kim, C. 1995. Disruption of a GATA motif in the Duffy gene promoter abolishes erythroid gene expression in Duffy-negative individuals. Nat. Genet. 10:224-228.
51. Arenzana-Seisdedos, F., and Parmentier, M. 2006. Genetics of resistance to HIV infection: role of coreceptors and co-receptor ligands. Semin. Immunol. 18:387-403. (Pubitemid 44511884)
52. Dean, M., et al. 1996. Genetic restriction of HIV- 1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science. 273:1856-1862. (Pubitemid 26322495)
53. Liu, R., et al. 1996. Homozygous defects in HIV-1 coreceptor accounts for resistance of some multiply- exposed individuals to HIV-1 infection. Cell. 86:367-377. (Pubitemid 26272077)
54. Samson, M., et al. 1996. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of teh CCR5 chemokine receptor gene. Nature. 382:722-725. (Pubitemid 26282179)
55. Brown, K.E., et al. 1994. Resistance to parvovirus B19 infection due to lack of virus receptor (erythrocyte P antigen). N. Engl. J. Med. 330:1192-1196.
56. Le Pendu, J., Ruvoen-Clouet, N., Kindberg, E., and Svensson, L. 2006. Mendelian resistance to human norovirus infections. Semin. Immunol. 18:375-386. (Pubitemid 44511886)
57. Marionneau, S., et al. 2002. Norwalk virus binds to histo-blood group antigens present on gastroduodenal epithelial cells of secretor individuals. Gastroenterology. 122:1967-1977. (Pubitemid 34651439)
58. Lindesmith, L., et al. 2003. Human susceptibility and resistance to Norwalk virus infection. Nat. Med. 9:548-553. (Pubitemid 36597100)
59. Thorven, M., et al. 2005. A homozygous nonsense mutation (428G - >A) in the human secretor (FUT2) gene provides resistance to symptomatic norovirus (GGII) infections. J. Virol. 79:15351-15355. (Pubitemid 43032317)
60. Genton, B., et al. 2008. Plasmodium vivax and mixed infections are associated with severe malaria in children: a prospective cohort study from Papua New Guinea. PLoS Med. 5:e127. (Pubitemid 351919109)
61. Tjitra, E., et al. 2008. Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua, Indonesia. PLoS Med. 5:e128. (Pubitemid 351919110)
62. Cavasini, C.E., et al. 2007. Duffy blood group gene polymorphisms among malaria vivax patients in four areas of the Brazilian Amazon region. Malar. J. 6:167.
63. Ryan, J.R., et al. 2006. Evidence for transmission of Plasmodium vivax among a duffy antigen negative population in Western Kenya. Am. J. Trop. Med. Hyg. 75:575-581.
64. Kwiatkowski, D.P. 2005. How malaria has affected the human genome and what human genetics can teach us about malaria. Am. J. Hum. Genet. 77:171-192.
65. Vogel, F., and Motulsky, A.G. 1997. Human genetics: problems and approaches. Springer. Berlin, Germany/ New York, New York, USA. 851 pp.
66. Modiano, D., et al. 2001. Haemoglobin C protects against clinical Plasmodium falciparum malaria. Nature. 414:305-308. (Pubitemid 33097806)
67. Stephens, J.C., et al. 1998. Dating the origin of the CCR5-Delta32 AIDS-resistance allele by the coalescence of haplotypes. Am. J. Hum. Genet. 62:1507-1515.
68. Novembre, J., Galvani, A.P., and Slatkin, M. 2005. The geographic spread of the CCR5 Delta32 HIVresistance allele. PLoS Biol. 3:e339. (Pubitemid 41652447)
69. Sabeti, P.C., et al. 2005. The case for selection at CCR5-Delta32. PLoS Biol. 3:e378.
70. Glass, W.G., et al. 2006. CCR5 deficiency increases risk of symptomatic West Nile virus infection. J. Exp. Med. 203:35-40. (Pubitemid 43139642)
71. Liu, Y., et al. 1998. Extensive polymorphism of the FUT2 gene in an African (Xhosa) population of South Africa. Hum. Genet. 103:204-210. (Pubitemid 28444661)
72. Fisher, R.A. 1918. The correlation between relatives on the supposition of Mendelian inheritance. Trans. R. Soc. Edinb. 52:399-433.
73. Edwards, J.H. 1969. Familial predisposition in man. Br. Med. Bull. 25:58-64.
74. Lalouel, J.M., Rao, D.C., Morton, N.E., and Elston, R.C. 1983. A unified model for complex segregation analysis. Am. J. Hum. Genet. 35:816-826.
75. Khoury, M.J., Beaty, T.H., and Cohen, B.H. 1993. Fundamentals of genetic epidemiology. Oxford University Press. New York, New York, USA. 383 pp.
76. Risch, N. 1990. Linkage strategies for genetically complex traits. III. The effect of marker polymorphism on analysis of affected relative pairs. Am. J. Hum. Genet. 46:242-253. (Pubitemid 20077592)
77. Risch, N., and Merikangas, K. 1996. The future of genetic studies of complex human diseases. Science. 273:1516-1517. (Pubitemid 26301653)
78. Marquet, S., et al. 1996. Genetic localization of a locus controlling the intensity of infection by Schistosoma mansoni on chromosome 5q31-q33. Nat. Genet. 14:181-184. (Pubitemid 26338800)
79. Baghdadi, J.E., et al. 2006. An autosomal dominant major gene confers predisposition to pulmonary tuberculosis in adults. J. Exp. Med. 203:1679-1684.
80. WHO. 2006. Global leprosy situation, beginning of 2008. Wkly. Epidemiol. Rec. 83:293-300.
81. Alcais, A., Mira, M., Casanova, J.L., Schurr, E., and Abel, L. 2005. Genetic dissection of immunity in leprosy. Curr. Opin. Immunol. 17:44-48.
82. Abel, L., and Demenais, F. 1988. Detection of major genes for susceptibility to leprosy and its subtypes. Am. J. Hum. Genet. 42:256-266.
83. Abel, L., et al. 1995. Complex segregation analysis of leprosy in southern Vietnam. Genet. Epidemiol. 12:63-82.
84. Siddiqui, M.R., et al. 2001. A major susceptibility locus for leprosy in India maps to chromosome 10p13. Nat. Genet. 27:439-441. (Pubitemid 32268428)
85. Mira, M.T., et al. 2003. Chromosome 6q25 is linked to susceptibility to leprosy in a Vietnamese population. Nat. Genet. 33:412-415.
86. Mira, M.T., et al. 2004. Susceptibility to leprosy is associated with PARK2 and PACRG. Nature. 427:636-640.
87. Schurr, E., Alcais, A., de Leseleuc, L., and Abel, L. 2006. Genetic predisposition to leprosy: a major gene reveals novel pathways of immunity to Mycobacterium leprae. Semin. Immunol. 18:404-410. (Pubitemid 44540197)
88. Alcais, A., et al. 2007. Stepwise replication identifies a low-producing lymphotoxin-alpha allele as a major risk factor for early-onset leprosy. Nat. Genet. 39:517-522 (Pubitemid 46514779)
89. Bellamy, R., et al. 1998. Variations in the NRAMP1 gene and susceptibility to tuberculosis in West Africans. N. Engl. J. Med. 338:640-644. (Pubitemid 28108433)
90. Greenwood, C.M., et al. 2000. Linkage of tuberculosis to chromosome 2q35 loci, including NRAMP1, in a large aboriginal Canadian family. Am. J. Hum. Genet. 67:405-416.
91. Malik, S., et al. 2005. Alleles of the NRAMP1 gene are risk factors for pediatric tuberculosis disease. Proc. Natl. Acad. Sci. U. S. A. 102:12183-12188. (Pubitemid 41291149)
92. Fellay, J., et al. 2007. A whole-genome association study of major determinants for host control of HIV-1. Science. 317:944-947. (Pubitemid 47301321)
93. Mackinnon, M.J., Mwangi, T.W., Snow, R.W., Marsh, K., and Williams, T.N. 2005. Heritability of malaria in Africa. PLoS Med. 2:e340.
94. Casanova, J.L., and Abel, L. 2005. Inborn errors of immunity to infection: the rule rather than the exception. J. Exp. Med. 202:197-201. (Pubitemid 41043814)
95. Pasteur, L. 1870. Etudes sur la maladie des vers a soie. La pébrine et la flacherie (tome I). Gauthier-Villars. Paris, France. 282 pp.
96. Antonarakis, S.E., and Beckmann, J.S. 2006. Mendelian disorders deserve more attention. Nat. Rev. Genet. 7:277-282.
97. Pritchard, J.K. 2001. Are rare variants responsible for susceptibility to complex diseases? Am. J. Hum. Genet. 69:124-137.
98. Casanova, J.L., and Abel, L. 2007. Primary immunodeficiencies: a field in its infancy. Science. 317:617-619. (Pubitemid 47229951)
99. Quintana-Murci, L., Alcais, A., Abel, L., and Casanova, J.L. 2007. Immunology in natura: clinical, epidemiological and evolutionary genetics of infectious diseases. Nat. Immunol. 8:1165-1171. (Pubitemid 350011752)
100. Coffey, A.J., et al. 1998. Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene. Nat. Genet. 20:129-135.